Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".

Title:	Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".
Authors:	Vallejo-Vaz, AJ Packard, CJ Ray, K
Item Type:	Journal Article
Issue Date:	29-May-2018
Date of Acceptance:	6-Feb-2018
URI:	http://hdl.handle.net/10044/1/58073
DOI:	https://dx.doi.org/10.1161/CIRCULATIONAHA.118.033781
ISSN:	0009-7322
Publisher:	American Heart Association
Start Page:	2419
End Page:	2420
Journal / Book Title:	Circulation
Volume:	22
Issue:	137
Copyright Statement:	© 2018 American Heart Association, Inc.
Sponsor/Funder:	Sanofi Aventis
Funder's Grant Number:	UKME-15-00020
Keywords:	Science & Technology Life Sciences & Biomedicine Cardiac & Cardiovascular Systems Peripheral Vascular Disease Cardiovascular System & Cardiology COHORT 1103 Clinical Sciences 1102 Cardiovascular Medicine And Haematology 1117 Public Health And Health Services Cardiovascular System & Hematology
Publication Status:	Published
Online Publication Date:	2018-05-29
Appears in Collections:	School of Public Health